| Literature DB >> 28930276 |
Dalmarcia de Sousa Carlos Mourão1, Talita Ferreira de Souza Pereira2, Danival José de Souza3, Aloísio Freitas Chagas Júnior4, Mateus Sunti Dalcin5, Ronice Alves Veloso6, Evelynne Urzêdo Leão7, Gil Rodrigues Dos Santos8.
Abstract
The Curvularia Leaf Spot is becoming more common due to the culture expansion and the low resistance of the cultivated genotypes in tropical regions. Thus, the objective was to evaluate the fungitoxicity of the essential oil of Cymbopogon citratus upon the phytopathogen Curvularia lunata, causative agent of the Curvularia Leaf Spot. There was realized pathogenicity tests of C. lunata in maize plants, phytotoxicity of the essential oil of C. citratus and gas chromatography attached, germination tests of the conidia, and of in vitro inhibition of C. lunata. Also, there were realized tests aiming at verifying the phytopathogen control in vivo. In the pathogenicity tests, there were verified symptoms of the disease in all of the suspensions tested on plants. It was observed that the essential oil concentrations of 7.5 µL mL-1 to 50 µL mL-1 were phytotoxic. The majoritarian chemical components of the essential oil of C. citratus were Geranial (41.46%) and Neral (32.43%). The concentrations of 5 and 7.5 µL mL-1 inhibited 100% of conidia germination. None of the concentrations evaluated effectively inhibited C. lunata mycelial growth in in vitro tests. In the preventive control, the concentration of 7.5 µL mL-1 was sufficient for the reduction of the progress of the disease, however the curative control was not efficient on the tested dosages.Entities:
Keywords: Zea mays; botanical fungicide; curative control; lemongrass; preventive control
Year: 2017 PMID: 28930276 PMCID: PMC5622397 DOI: 10.3390/medicines4030062
Source DB: PubMed Journal: Medicines (Basel) ISSN: 2305-6320
Figure 1Severity of the Curvularia Leaf Spot disease in maize plants, submitted to the inoculation with different conidia concentrations of Curvularia lunata. (A—Control; B—101 conidia mL−1; C—102 conidia mL−1; D—103 conidia mL−1; E—104 conidia mL−1; F—105 conidia mL−1; G—106 conidia mL−1).
Figure 2Phytotoxicity (Damaged leaf area x Incubation days) of different C. citratus essential oil concentrations in maize plants. Treatments (2.5 µL mL−1, 5 µL mL−1, 7.5 µL mL−1, 10 µL mL−1, and 50 µL mL−1) positive control (distilled water), negative control—(fungicide—methyl-thiophanate 2 mg mL−1).
Mean mycelial diameter (mm) of Curvularia lunata under different concentrations of the C. citratus essential oil.
| Treatments | Avaliation Time (Incubation Days) | Regression Equation | R2 | ||||
|---|---|---|---|---|---|---|---|
| 2 | 4 | 6 | 8 | 10 | |||
| PC | 26.21 | 44.69 | 59.44 | 68.96 | 80.56 | y = 13.297x + 16.081 | 0.98 |
| NC a | 25.27 | 42.51 | 59.44 | 67.4 | 78.11 | y = 13.057x + 15.375 | 0.97 |
| NC b | 8.59 | 9.14 | 9.74 | 9.94 | 10.51 | y = 0.464x + 8.192 | 0.98 |
| C1 | 25.06 | 40.90 | 55.12 | 69.72 | 82.89 | y = 14.448x + 11.394 | 0.99 |
| C2 | 24.36 | 40.22 | 53.31 | 69.05 | 82.62 | y = 14.535x + 10.307 | 0.99 |
| C3 | 21.4 | 36.27 | 52.35 | 68.29 | 82.36 | y = 15.394x + 5.952 | 0.99 |
| C4 | 19.97 | 36.08 | 51.96 | 66.74 | 81.35 | y = 15.342x + 5.194 | 0.99 |
| C5 | 18.09 | 35.54 | 50.74 | 66.61 | 77.37 | y = 14.963x + 4.781 | 0.99 |
PC: Positive control (distilled water), NC a: Negative control 1 (methyl-thiophanate under Curvularia), NC b: Negative control 2 (methyl-thiophanate under Fusarium sp.), C1–C5: Concentrations in µL mL−1 (C1 = 2.5 µL mL−1, C2 = 5 µL mL−1, C3 = 7.5 µL mL−1, C4 = 10 µL mL−1 and C5= 50 µL mL−1).
Figure 3Conidia germination inhibition of Curvularia lunata under crescent dosages of C. citratus (Cymbopogon citratus) essential oil. Treatments: 0 (0.0 µL mL−1), 2 (Negative control, with methyl-thiophanate 2 mg mL−1). Concentrations of C. citratus essential oil = 0.625 µL mL−1; 1.25 µL mL−1; 2.5 µL mL−1; 5 µL mL−1 and 7.5 µL mL−1).
Chemical components of the Cymbopogon citratus essential oil identified by mass spectrometry (CG/MS) and its respective levels expressed in percentage.
| Lemongrass Essential Oil | |||
|---|---|---|---|
| Constituints | RT | IR | (%) |
| Mircene | 7.742 | 986 | 9.73 |
| (Z)-β-oxime | 9.344 | 1020 | 0.32 |
| (E)-β-oxime | 9.753 | 1029 | 0.16 |
| Linalool | 11.845 | 1074 | 1.64 |
| Neral | 17.885 | 1209 | 32.43 |
| Geraniol | 18.375 | 1220 | 4.52 |
| Geranial | 19.233 | 1239 | 41.46 |
| 2-undecanone | 20.099 | 1359 | 0.35 |
| Geranyl acetate | 23.737 | 1443 | 0.42 |
| E-Caryofylene | 31.997 | 1641 | 0.17 |
| Anothers | - | - | 8.8 |
| Total | - | - | 100 |
RT = retention time; IR = calculated retention rate.
Figure 4Area Under Disease Progress Curve (AUDPC) for preventive and curative in vivo under positive control with water (0 = 0.0 µL mL−1) and negative control with methyl-thiophanate (6 = 2.0 mg mL−1), with five different concentrations (1 = 0.625 µL mL−1, 2 = 1.25 µL mL−1, 3 = 2.5 µL mL−1, 4 = 5 µL mL−1, and 5 = 7.5 µL mL−1) of the Cymbopogon citratus essential oil.